AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Demonstrating your value is crucial for securing a salary increase. Learn effective methods to showcase your contributions and worth.
21,252 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Braze beat Q4 expectations with $205.17 million in revenue and 27.9% annual growth, as analysts weigh the AI-driven g...
Snowflake posted a record quarter, but its stock trades far from its peak as investors weigh whether AI-driven growth...
Meta Platforms is signaling a durable AI-led growth path through vertical control of compute, power, silicon, and ads...
Shield AI's new CEO asserts the company is at a pivotal moment, as its battlefield-tested drones and software shift f...
Aave secures FCA registrations for its UK entities and a MiCAR CASP license in Ireland, creating a regulated path fro...
A trading halt and a sharp drop put Lucid in the spotlight, but the company pushed back on bankruptcy chatter. This g...
Choosing how to borrow can feel confusing. This guide breaks down personal loans and credit cards, shows when each op...
Millrose Properties marks its first year as an independent REIT with solid Q1 2026 earnings, expanding its builder ne...
BWLP’s Q1 2026 results offer a window into fleet utilization, charter rates, and balance-sheet moves. This guide brea...
When a tech giant pours billions into warehouse robotics, investors want to know what happens next. This guide breaks...
Rivian is targeting a major production shift with the R2 lineup. This guide weighs the bull and bear cases for rivian...